Lunai Bioworks 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-305.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2Q50.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Show more...
CEO
ISIN
US29350E2037
WKN
000A41K8P

Listings

0 Comments

Share your thoughts

FAQ

What is Lunai Bioworks stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lunai Bioworks stocks are traded under the ticker 2Q50.F.
What is Lunai Bioworks revenue for the last year?
Lunai Bioworks revenue for the last year amounts to 0 EUR.
What is Lunai Bioworks net income for the last year?
2Q50.F net income for the last year is -305.06M EUR.
When did Lunai Bioworks complete a stock split?
The last stock split for Lunai Bioworks was on September 30, 2025 with a ratio of 1:10.